Price$1.73-0.01 (-0.58%)
01:30 PM07:45 PM
News · 26 weeks44-44%
2025-12-282026-06-21
Mix3390d
- Insider11(33%)
- SEC Filings9(27%)
- Other9(27%)
- Leadership2(6%)
- Earnings2(6%)
Latest news
25 items- PRSpectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness MonthDALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month. In this milestone year, during the month of June the ABWM Foundation will continue its mission of raising awareness, empowering certified wound care specialists, and transforming lives. "Wound Healing Awareness Month is an important reminder that patients living with painful, sometimes complex burn wounds require a timely
- PRSpectral AI to Participate in 2026 British Burn Association Annual ConferenceDALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its participation in the upcoming British Burn Association ("BBA") Annual Meeting, being held June 17-19, 2026 at the Nottingham Trent University, Nottingham, England. The Company's DeepView® System will be on display at Stand #22 and will be the subject of multiple podium and poster presentations during the conference. This innovative, first-of-its-kind burn wound assessment technology was granted De Novo Classification by the U.S
- SECSpectral AI Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- INSIDERDirector Dimaio John Michael was granted 17,500 shares, increasing direct ownership by 0.66% to 2,687,847 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- PRSpectral AI Announces Voting Results of Annual Meeting of StockholdersDALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026. The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from the U.S. Food and Drug Administration ("FDA"). 2026 Annual Meeting of Stockholders A total of 17,267,570 shares representing 54.3% of the Company's total shares outstanding were re
- INSIDERDirector Dimaio John Michael was granted 32,233 shares, increasing direct ownership by 1% to 2,670,347 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- SECSpectral AI Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- PRSpectral AI Receives FDA De Novo Clearance for DeepView® System for Burn IndicationDALLAS, May 26, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the U.S. Food and Drug Administration (FDA) granted De Novo Classification for its DeepView® System. With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States. The DeepView System is intended for use in burn care in various settings, including burn centers, trauma centers, and emergency departments. "We are pleased that the FDA has recognized our novel technology. I a
- INSIDERDirector Sadagopan Deepak was granted 25,000 shares (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERDirector Cotton Richard John was granted 14,700 shares, increasing direct ownership by 15% to 111,477 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERDirector Dimaio John Michael was granted 26,887 shares, increasing direct ownership by 1% to 2,638,114 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- PRReal-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare OpportunitiesAUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods is intensifyi
- PRSpectral AI Announces 2026 First Quarter Financial ResultsDevelopment Work for DeepView® Systems Continues with Support of Recently Awarded $31.7 Million of Funding from BARDA Reiterates Annual Revenues Guidance DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended March 31, 2026. "Our results for the 2026 first quarter reflected the progress we have made in developing our DeepView® System for burn indication under the base phase of our Project BioShield Contract with BARDA," said Vincent Capone, Chief
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Spectral AI Inc.SCHEDULE 13G/A - Spectral AI, Inc. (0001833498) (Subject)
- PRSpectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation ConferenceDALLAS, April 30, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has received the "Small Business Innovator Award" at the inaugural Texas Innovation Conference, held on April 22-23, 2026 at the campus of Texas Christian University. The conference highlighted organizations and thought leaders that are turning research into real-world results, bringing together a select group of high-impact innovators, including startups, researchers, and ecosystem leaders. The Texas Innovation Awards ceremo
- PRSpectral AI Schedules 2026 First Quarter Financial Results and Conference CallDALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2026 on Tuesday, May 12, 2026 after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results. Investors interested in participating in the live call can dial into the conference call as follows: 833-890-6620 – U.S.412-564-3789 – International In addit
- INSIDERDirector Dimaio John Michael was granted 100,000 shares, increasing direct ownership by 4% to 2,611,227 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERDirector Cotton Richard John was granted 29,850 shares, increasing direct ownership by 45% to 96,777 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERDirector Snyder Marion Ann was granted 25,000 shares (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- INSIDERChief Executive Officer Capone Vincent S. was granted 100,000 shares, increasing direct ownership by 54% to 286,450 units (SEC Form 4)4 - Spectral AI, Inc. (0001833498) (Issuer)
- PRSpectral AI's DeepView® System Showcased at 2026 American Burn Association Annual MeetingDALLAS, April 22, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today shared a recap from the 2026 Annual Meeting of the American Burn Association, held April 14-17, 2026 in Orlando, Florida. The theme of this year's conference, Leading Burn Care into Tomorrow, provided a rich and relevant platform for U.S. and UK clinicians to present various aspects of the DeepView System® to more than 2,200 clinicians, researchers, and burn care leaders from across the globe. The DeepView System is an AI-driven, predictive
- SECSpectral AI Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Spectral AI, Inc. (0001833498) (Filer)
- PRSpectral AI Announces Annual Meeting of StockholdersDALLAS, April 20, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that its 2026 Annual Meeting of Stockholders ("Annual Meeting") will take place at 9:30 a.m. Central Daylight Time on Friday, May 29, 2026. Only stockholders of record at the close of business on April 1, 2026, the record date, will be entitled to vote at the Annual Meeting. To be admitted to the Annual Meeting, stockholders as of the record date can either attend in person at the Company's corporate headquarters or virtually by reg
- SECSEC Form DEFA14A filed by Spectral AI Inc.DEFA14A - Spectral AI, Inc. (0001833498) (Filer)
- SECSEC Form DEF 14A filed by Spectral AI Inc.DEF 14A - Spectral AI, Inc. (0001833498) (Filer)
MDAI FAQ
6 questionsWhere does MDAI stock trade?
Spectral AI Inc. (MDAI) is listed on NASDAQ.What sector and industry is MDAI in?
Spectral AI Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Spectral AI Inc. go public?
Spectral AI Inc. (MDAI) completed its IPO in 2021.What are analysts saying about MDAI?
Spectral AI Inc. has had 1 recent analyst action on file. The most recent action was from BTIG Research: Buy with a $400.00 price target on 2024-01-23. Recent price targets cluster around $400.00.What companies are similar to MDAI?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare MDAI side-by-side with any of them on Quantisnow.How can I track MDAI on Quantisnow?
Quantisnow aggregates Spectral AI Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDAI to receive live email and push alerts on every new disclosure.